메뉴 건너뛰기




Volumn 66, Issue 10, 2014, Pages 2694-2705

Induced CD8+FoxP3+ treg cells in rheumatoid arthritis are modulated by p38 phosphorylation and monocytes expressing membrane tumor necrosis factor α and CD86

Author keywords

[No Author keywords available]

Indexed keywords

BLOCKING ANTIBODY; CD14 ANTIGEN; CD16 ANTIGEN; CD28 ANTIGEN; CD4 ANTIGEN; CD86 ANTIGEN; GAMMA INTERFERON; HLA DR ANTIGEN; INTERLEUKIN 17; MITOGEN ACTIVATED PROTEIN KINASE P38; MONOCLONAL ANTIBODY CD3; NEUTRALIZING ANTIBODY; OKT 3; OTELIXIZUMAB; T LYMPHOCYTE RECEPTOR; TRANSCRIPTION FACTOR FOXP3; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 2; CD86 PROTEIN, HUMAN; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, HUMAN;

EID: 84908375128     PISSN: 23265191     EISSN: 23265205     Source Type: Journal    
DOI: 10.1002/art.38761     Document Type: Article
Times cited : (21)

References (31)
  • 1
    • 3543140687 scopus 로고    scopus 로고
    • Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNFα therapy
    • Ehrenstein MR, Evans JG, Singh A, Moore S, Warnes G, Isenberg DA, et al. Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNFα therapy. J Exp Med 2004; 200: 277-85.
    • (2004) J Exp Med , vol.200 , pp. 277-285
    • Ehrenstein, M.R.1    Evans, J.G.2    Singh, A.3    Moore, S.4    Warnes, G.5    Isenberg, D.A.6
  • 2
    • 0141796312 scopus 로고    scopus 로고
    • TGF-β-dependent mechanisms mediate restoration of self-tolerance induced by antibodies to CD3 in overt autoimmune diabetes
    • Belghith M, Bluestone JA, Barriot S, Megret J, Bach JF, Chatenoud L,. TGF-β-dependent mechanisms mediate restoration of self-tolerance induced by antibodies to CD3 in overt autoimmune diabetes. Nat Med 2003; 9: 1202-8.
    • (2003) Nat Med , vol.9 , pp. 1202-1208
    • Belghith, M.1    Bluestone, J.A.2    Barriot, S.3    Megret, J.4    Bach, J.F.5    Chatenoud, L.6
  • 3
    • 26444515022 scopus 로고    scopus 로고
    • TCR stimulation with modified anti-CD3 mAb expands CD8+ T cell population and induces CD8+CD25+ Tregs
    • Bisikirska B, Colgan J, Luban J, Bluestone JA, Herold KC,. TCR stimulation with modified anti-CD3 mAb expands CD8+ T cell population and induces CD8+CD25+ Tregs. J Clin Invest 2005; 115: 2904-13.
    • (2005) J Clin Invest , vol.115 , pp. 2904-2913
    • Bisikirska, B.1    Colgan, J.2    Luban, J.3    Bluestone, J.A.4    Herold, K.C.5
  • 6
    • 79551715405 scopus 로고    scopus 로고
    • Human CD3 transgenic mice: Preclinical testing of antibodies promoting immune tolerance
    • Kuhn C, You S, Valette F, Hale G, van Endert P, Bach JF, et al. Human CD3 transgenic mice: preclinical testing of antibodies promoting immune tolerance. Sci Transl Med 2011; 3: 68ra10.
    • (2011) Sci Transl Med , vol.3 , pp. 68ra10
    • Kuhn, C.1    You, S.2    Valette, F.3    Hale, G.4    Van Endert, P.5    Bach, J.F.6
  • 7
    • 20044375937 scopus 로고    scopus 로고
    • A single course of anti-CD3 monoclonal antibody hOKT3γ1(Ala-Ala) results in improvement in C-peptide responses and clinical parameters for at least 2 years after onset of type 1 diabetes
    • Herold KC, Gitelman SE, Masharani U, Hagopian W, Bisikirska B, Donaldson D, et al. A single course of anti-CD3 monoclonal antibody hOKT3γ1(Ala-Ala) results in improvement in C-peptide responses and clinical parameters for at least 2 years after onset of type 1 diabetes. Diabetes 2005; 54: 1763-9.
    • (2005) Diabetes , vol.54 , pp. 1763-1769
    • Herold, K.C.1    Gitelman, S.E.2    Masharani, U.3    Hagopian, W.4    Bisikirska, B.5    Donaldson, D.6
  • 9
    • 80051471700 scopus 로고    scopus 로고
    • Teplizumab for treatment of type 1 diabetes (Protégé study): 1-year results from a randomised, placebo-controlled trial
    • for the Protégé Trial Investigators
    • Sherry N, Hagopian W, Ludvigsson J, Jain SM, Wahlen J, Ferry RJ Jr, et al, for the Protégé Trial Investigators. Teplizumab for treatment of type 1 diabetes (Protégé study): 1-year results from a randomised, placebo-controlled trial. Lancet 2011; 378: 487-97.
    • (2011) Lancet , vol.378 , pp. 487-497
    • Sherry, N.1    Hagopian, W.2    Ludvigsson, J.3    Jain, S.M.4    Wahlen, J.5    Ferry, R.J.6
  • 10
    • 0023945481 scopus 로고
    • The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis
    • Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315-24.
    • (1988) Arthritis Rheum , vol.31 , pp. 315-324
    • Arnett, F.C.1    Edworthy, S.M.2    Bloch, D.A.3    McShane, D.J.4    Fries, J.F.5    Cooper, N.S.6
  • 11
    • 74849107553 scopus 로고    scopus 로고
    • Anti-CD3 therapy expands the numbers of CD4+ and CD8+ Treg cells and induces sustained amelioration of collagen-induced arthritis
    • Notley CA, McCann FE, Inglis JJ, Williams RO,. Anti-CD3 therapy expands the numbers of CD4+ and CD8+ Treg cells and induces sustained amelioration of collagen-induced arthritis. Arthritis Rheum 2010; 62: 171-8.
    • (2010) Arthritis Rheum , vol.62 , pp. 171-178
    • Notley, C.A.1    McCann, F.E.2    Inglis, J.J.3    Williams, R.O.4
  • 12
    • 84869020571 scopus 로고    scopus 로고
    • Th17 cells are restrained by Treg cells via the inhibition of interleukin-6 in patients with rheumatoid arthritis responding to anti-tumor necrosis factor antibody therapy
    • McGovern JL, Nguyen DX, Notley CA, Mauri C, Isenberg DA, Ehrenstein MR,. Th17 cells are restrained by Treg cells via the inhibition of interleukin-6 in patients with rheumatoid arthritis responding to anti-tumor necrosis factor antibody therapy. Arthritis Rheum 2012; 64: 3129-38.
    • (2012) Arthritis Rheum , vol.64 , pp. 3129-3138
    • McGovern, J.L.1    Nguyen, D.X.2    Notley, C.A.3    Mauri, C.4    Isenberg, D.A.5    Ehrenstein, M.R.6
  • 13
    • 84860228482 scopus 로고    scopus 로고
    • Reversal of autoimmune diabetes by restoration of antigen-specific tolerance using genetically modified Lactococcus lactis in mice
    • Takiishi T, Korf H, Van Belle TL, Robert S, Grieco FA, Caluwaerts S, et al. Reversal of autoimmune diabetes by restoration of antigen-specific tolerance using genetically modified Lactococcus lactis in mice. J Clin Invest 2012; 122: 1717-25.
    • (2012) J Clin Invest , vol.122 , pp. 1717-1725
    • Takiishi, T.1    Korf, H.2    Van Belle, T.L.3    Robert, S.4    Grieco, F.A.5    Caluwaerts, S.6
  • 15
    • 33846446041 scopus 로고    scopus 로고
    • Anti-TNF-α therapy induces a distinct regulatory T cell population in patients with rheumatoid arthritis via TGF-β
    • Nadkarni S, Mauri C, Ehrenstein MR,. Anti-TNF-α therapy induces a distinct regulatory T cell population in patients with rheumatoid arthritis via TGF-β. J Exp Med 2007; 204: 33-9.
    • (2007) J Exp Med , vol.204 , pp. 33-39
    • Nadkarni, S.1    Mauri, C.2    Ehrenstein, M.R.3
  • 16
    • 0037963473 scopus 로고    scopus 로고
    • Blood monocytes consist of two principal subsets with distinct migratory properties
    • Geissmann F, Jung S, Littman DR,. Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity 2003; 19: 71-82.
    • (2003) Immunity , vol.19 , pp. 71-82
    • Geissmann, F.1    Jung, S.2    Littman, D.R.3
  • 19
    • 0028866022 scopus 로고
    • The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor
    • Grell M, Douni E, Wajant H, Lohden M, Clauss M, Maxeiner B, et al. The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor. Cell 1995; 83: 793-802.
    • (1995) Cell , vol.83 , pp. 793-802
    • Grell, M.1    Douni, E.2    Wajant, H.3    Lohden, M.4    Clauss, M.5    Maxeiner, B.6
  • 21
    • 36749081557 scopus 로고    scopus 로고
    • Optimal induction of T helper 17 cells in humans requires T cell receptor ligation in the context of Toll-like receptor-activated monocytes
    • Evans HG, Suddason T, Jackson I, Taams LS, Lord GM,. Optimal induction of T helper 17 cells in humans requires T cell receptor ligation in the context of Toll-like receptor-activated monocytes. Proc Natl Acad Sci U S A 2007; 104: 17034-9.
    • (2007) Proc Natl Acad Sci U S A , vol.104 , pp. 17034-17039
    • Evans, H.G.1    Suddason, T.2    Jackson, I.3    Taams, L.S.4    Lord, G.M.5
  • 22
    • 58049196774 scopus 로고    scopus 로고
    • Defects in CTLA-4 are associated with abnormal regulatory T cell function in rheumatoid arthritis
    • Flores-Borja F, Jury EC, Mauri C, Ehrenstein MR,. Defects in CTLA-4 are associated with abnormal regulatory T cell function in rheumatoid arthritis. Proc Natl Acad Sci U S A 2008; 105: 19396-401.
    • (2008) Proc Natl Acad Sci U S A , vol.105 , pp. 19396-19401
    • Flores-Borja, F.1    Jury, E.C.2    Mauri, C.3    Ehrenstein, M.R.4
  • 24
    • 77949908711 scopus 로고    scopus 로고
    • + CD8 T cells with suppressive potential in colorectal mucosa following a pathogenic simian immunodeficiency virus infection correlates with diminished antiviral T cell response and viral control
    • + CD8 T cells with suppressive potential in colorectal mucosa following a pathogenic simian immunodeficiency virus infection correlates with diminished antiviral T cell response and viral control. J Immunol 2010; 184: 1690-701.
    • (2010) J Immunol , vol.184 , pp. 1690-1701
    • Nigam, P.1    Velu, V.2    Kannanganat, S.3    Chennareddi, L.4    Kwa, S.5    Siddiqui, M.6
  • 27
    • 78649900433 scopus 로고    scopus 로고
    • Pathogenic T cells have a paradoxical protective effect in murine autoimmune diabetes by boosting Tregs
    • Grinberg-Bleyer Y, Saadoun D, Baeyens A, Billiard F, Goldstein JD, Gregoire S, et al. Pathogenic T cells have a paradoxical protective effect in murine autoimmune diabetes by boosting Tregs. J Clin Invest 2010; 120: 4558-68.
    • (2010) J Clin Invest , vol.120 , pp. 4558-4568
    • Grinberg-Bleyer, Y.1    Saadoun, D.2    Baeyens, A.3    Billiard, F.4    Goldstein, J.D.5    Gregoire, S.6
  • 29
    • 84868629269 scopus 로고    scopus 로고
    • TNF signaling drives myeloid-derived suppressor cell accumulation
    • Zhao X, Rong L, Zhao X, Li X, Liu X, Deng J, et al. TNF signaling drives myeloid-derived suppressor cell accumulation. J Clin Invest 2012; 122: 4094-104.
    • (2012) J Clin Invest , vol.122 , pp. 4094-4104
    • Zhao, X.1    Rong, L.2    Zhao, X.3    Li, X.4    Liu, X.5    Deng, J.6
  • 30
    • 0346100668 scopus 로고    scopus 로고
    • Regulation of TCR-mediated T cell activation by TNF-RII
    • Aspalter RM, Eibl MM, Wolf HM,. Regulation of TCR-mediated T cell activation by TNF-RII. J Leukoc Biol 2003; 74: 572-82.
    • (2003) J Leukoc Biol , vol.74 , pp. 572-582
    • Aspalter, R.M.1    Eibl, M.M.2    Wolf, H.M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.